Literature DB >> 8236277

Myeloperoxidase-mediated activation of xenobiotics by human leukocytes.

A H Hofstra1, J P Uetrecht.   

Abstract

Peripheral blood leukocytes contain a variety of enzymes that are capable of metabolising xenobiotics. The enzyme myeloperoxidase (MPO) appears to be the most important for drug metabolism. MPO is a peroxidase/oxidase and generates the powerful oxidant hypochlorous acid. MPO- or MPO-generated oxidants are capable of oxidizing a wide variety of compounds and a broad range of functional groups, especially those that contain nitrogen and sulfur. Leukocytes have a role in immune response; therefore, reactive intermediates generated by leukocyte metabolism of xenobiotics may have a role in idiosyncratic drug reactions, particularly those that are immune-mediated such as drug-induced lupus or agranulocytosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8236277     DOI: 10.1016/0300-483x(93)90066-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

Review 1.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

Review 2.  Role of bioactivation in drug-induced hypersensitivity reactions.

Authors:  Joseph P Sanderson; Dean J Naisbitt; B Kevin Park
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

3.  Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897.

Authors:  Christine B Ambrosone; William E Barlow; Wanda Reynolds; Robert B Livingston; I-Tien Yeh; Ji-Yeob Choi; Warren Davis; James M Rae; Li Tang; Laura R Hutchins; Peter M Ravdin; Silvana Martino; C Kent Osborne; Alan P Lyss; Daniel F Hayes; Kathy S Albain
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

4.  Sulphoxidation reaction catalysed by myeloperoxidase from human leucocytes.

Authors:  C Capeillère-Blandin; C Martin; N Gaggero; P Pasta; G Carrea; S Colonna
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

5.  Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

Authors:  Huai Liu; Bin Qi; Xiang Guo; Lin-Quan Tang; Qiu-Yan Chen; Lu Zhang; Ling Guo; Dong-Hua Luo; Pei-Yu Huang; Hao-Yuan Mo; Yan-Qun Xiang; Fang Qiu; Rui Sun; Ying Zhang; Ming-Yuan Chen; Yi-Jun Hua; Xing Lv; Lin Wang; Chong Zhao; Ka-Jia Cao; Chao-Nan Qian; Ming-Huang Hong; Hai-Qiang Mai
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.